导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.90% | 1233/1259 |
| 近一周 | -0.01% | 191/1304 |
| 近一月 | -0.65% | 487/1296 |
| 近一季 | -0.36% | 842/1288 |
| 近半年 | -1.44% | 1258/1283 |
| 近一年 | -0.64% | 1221/1253 |
| 近两年 | 7.13% | 942/1200 |
| 近三年 | 1.01% | 957/1072 |
| 成立以来 | 25.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.86% 1224/1341 |
1.51% 389/1366 |
-1.63% 1335/1361 |
- - |
| 2024 | 7.52% 309/1373 |
2.28% 229/1403 |
1.85% 262/1402 |
0.61% 1100/1374 |
2.59% 194/1373 |
| 2023 | -3.89% 1058/1401 |
-1.01% 1297/1367 |
-4.53% 1333/1388 |
0.23% 247/1403 |
1.46% 26/1401 |
| 2022 | -9.43% 1040/1336 |
-9.91% 1065/1128 |
7.43% 20/1307 |
-10.19% 1290/1325 |
4.19% 11/1336 |
| 2021 | 6.03% 276/1165 |
-4.07% 578/633 |
5.38% 59/921 |
1.19% 309/1070 |
3.65% 87/1163 |
| 2020 | 21.62% 43/650 |
3.33% 18/336 |
9.80% 23/504 |
-1.13% 495/587 |
8.42% 42/675 |
| 2019 | - - |
- - |
- - |
2.98% 79/359 |
1.27% 301/372 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 中信建投聚利混合C VS. () |